All Things CLL With Nitin Jain
Healthcare Unfiltered
00:00
Ibrutinib Akhala and Zenu: Which Is Better?
In the frontline we have Ibrutinib Akhala and Zenu. We are extrapolating that safety from the relapsed disease to this frontline because you know efficacy may be different obviously. Between the two I don't think there is any way we can distinguish them in their minor final points but I think it really is your own preference to see which one we want to pick for CLL. And then the third pile is the veneetal plaques plus veneETal map and that's given for one year as a good school.
Transcript
Play full episode
